Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes from a US Payor Perspective

被引：0
作者：
Alshannaq, Hamza
Norman, Gregory J.
Lynch, Peter M.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1035-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1035-P
引用
收藏
页数：2
相关论文
共 50 条
[1]   Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Intensive Insulin Therapy in Australia [J].
Alshannaq, Hamza ;
Ahmed, Moin ;
Norman, Gregory J. ;
Simmons, David .
DIABETES, 2024, 73
[2]   Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System vs. Self-Monitoring of Blood Glucose in Type 2 Diabetes Patients on Insulin in Canada [J].
Isitt, John J. ;
Roze, Stephane ;
Cogswell, Gregory ;
Lynch, Peter M. .
DIABETES, 2022, 71
[3]   Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada [J].
Alshannaq, Hamza ;
Isitt, John J. ;
Pollock, Richard F. ;
Norman, Gregory J. ;
Cogswell, Greg ;
Lynch, Peter M. ;
Roze, Stephane .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (10)
[4]   Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain [J].
Merino-Torres, Juan Francisco ;
Ilham, Sabrina ;
Alshannaq, Hamza ;
Pollock, Richard F. ;
Ahmed, Waqas ;
Norman, Gregory .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2024, 16 :785-797
[5]   Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK [J].
Isitt, John J. ;
Roze, Stephane ;
Sharland, Helen ;
Cogswell, Greg ;
Alshannaq, Hamza ;
Norman, Gregory J. ;
Lynch, Peter M. .
DIABETES THERAPY, 2022, 13 (11-12) :1875-1890
[6]   Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK [J].
John J. Isitt ;
Stéphane Roze ;
Helen Sharland ;
Greg Cogswell ;
Hamza Alshannaq ;
Gregory J. Norman ;
Peter M. Lynch .
Diabetes Therapy, 2022, 13 :1875-1890
[7]   Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France [J].
Alshannaq, Hamza ;
Pollock, Richard F. ;
Joubert, Michael ;
Ahmed, Waqas ;
Norman, Gregory J. ;
Lynch, Peter M. ;
Roze, Stephane .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
[8]   Cost-effectiveness of Dexcom real-time continuous glucose monitoring vs self-monitoring of blood glucose in patients with type 2 diabetes on intensive insulin therapy in Estonia [J].
Ilham, S. ;
Alshannaq, H. ;
Norman, G. J. .
DIABETOLOGIA, 2024, 67 :S388-S388
[9]   COST-EFFECTIVENESS OF REAL-TIME CONTINUOUS GLUCOSE MONITORING SYSTEM (RTCGM) VERSUS SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN PEOPLE WITH TYPE 2 DIABETES ON INSULIN THERAPY IN FRANCE [J].
Alshannaq, H. ;
Roze, S. ;
Joubert, M. ;
Norman, G. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 :A142-A143
[10]   COST-EFFECTIVENESS OF A REAL-TIME CONTINUOUS GLUCOSE MONITORING SYSTEM VERSUS SELF-MONITORING OF BLOOD GLUCOSE IN TYPE 2 DIABETES PATIENTS ON INSULIN IN THE UNITED KINGDOM [J].
Isitt, J. ;
Roze, S. ;
Leelarathna, L. ;
Cogswell, G. ;
Norman, G. ;
Lynch, P. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 :A32-A33
12345